cell treatments in world's first is drawing significant interest across the industry.
The Japanese government on Friday conditionally approved the commercialization of two regenerative medicine products prepared from induced pluripotent
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →